Chiral Quest, Inc. Set for $13M Series B Financing
1/13/2009 6:48:59 AM
More...
|
Chiral Quest, Inc. Closes $13 Million Series B
11/17/2008 3:44:12 PM
More...
|
Sumitomo Corporation Named Exclusive Distribution and Sales Agent for Chiral Quest, Inc.
4/15/2008 8:14:59 AM
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Strengthens Balance Sheet Through Sale of Chiral Quest, Inc. Subsidiary and Completion of Private Placement
7/16/2007 11:25:30 AM
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Exploring Strategic Alternatives For Chiral Quest, Inc. Subsidiary To Focus Resources On Drug Development; Possible Sale Of Business
9/29/2006 1:13:55 PM
More...
|
Chiral Quest, Inc. Announces Formation Of Chiral Consortium With CSS And IEP
10/19/2005 5:12:40 PM
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Appoints Daniel Greenleaf President And Chief Executive Officer
10/19/2005 5:12:38 PM
More...
|
Exclusive Wall Street Network Audio Interview With Ron Brandt, President And CEO Of VioQuest Pharmaceuticals, Inc. (VQPH.OB) Available Now At www.wallst.net
10/19/2005 5:12:25 PM
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Subsidiary Chiral Quest, Inc. Enters Into Distribution Agreement With Selectchemie AG
10/19/2005 5:12:06 PM
More...
|
VioQuest Pharmaceuticals, Inc. (VQPH.OB) Subsidiary Chiral Quest, Inc., Announces Ligand Technology Relationship With Pfizer Inc. (PFE)
10/19/2005 5:11:52 PM
More...
|
|